BioLineRx (BLRX) Assets Average (2013 - 2025)

BioLineRx's Assets Average history runs 13 years deep, the most recent figure standing at $40.4 million for Q4 2025.

• In Q4 2025, Assets Average fell 11.94% year-over-year to $40.4 million; the TTM figure through Dec 2025 stood at $40.4 million (down 11.94% YoY), while the FY2025 annual figure was $39.9 million, down 22.39% from the prior year.
• Assets Average was $40.4 million for Q4 2025 at BioLineRx, down from $41.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $89.1 million in Q3 2021 to a low of $40.4 million in Q4 2025.
• Historically, Assets Average has averaged $63.3 million across 5 years, with a median of $61.2 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Assets Average jumped 80.33% in 2021, then retreated 29.2% in 2025.
• A 5-year view of Assets Average shows it stood at $84.1 million in 2021, then decreased by 6.08% to $79.0 million in 2022, then declined by 26.12% to $58.4 million in 2023, then dropped by 21.52% to $45.8 million in 2024, then declined by 11.94% to $40.4 million in 2025.
• The last three Assets Average figures came in at $40.4 million (Q4 2025), $41.5 million (Q3 2025), and $43.4 million (Q2 2025), per Business Quant data.